Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market by Application
1.3.1 Global HER2 Antibodies Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Antibodies Market Perspective (2018-2033)
2.2 HER2 Antibodies Growth Trends by Region
2.2.1 Global HER2 Antibodies Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 HER2 Antibodies Historic Market Size by Region (2018-2023)
2.2.3 HER2 Antibodies Forecasted Market Size by Region (2024-2033)
2.3 HER2 Antibodies Market Dynamics
2.3.1 HER2 Antibodies Industry Trends
2.3.2 HER2 Antibodies Market Drivers
2.3.3 HER2 Antibodies Market Challenges
2.3.4 HER2 Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibodies Players by Revenue
3.1.1 Global Top HER2 Antibodies Players by Revenue (2018-2023)
3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2018-2023)
3.2 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibodies Revenue
3.4 Global HER2 Antibodies Market Concentration Ratio
3.4.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2022
3.5 HER2 Antibodies Key Players Head office and Area Served
3.6 Key Players HER2 Antibodies Product Solution and Service
3.7 Date of Enter into HER2 Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibodies Breakdown Data by Type
4.1 Global HER2 Antibodies Historic Market Size by Type (2018-2023)
4.2 Global HER2 Antibodies Forecasted Market Size by Type (2024-2033)
5 HER2 Antibodies Breakdown Data by Application
5.1 Global HER2 Antibodies Historic Market Size by Application (2018-2023)
5.2 Global HER2 Antibodies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America HER2 Antibodies Market Size (2018-2033)
6.2 North America HER2 Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America HER2 Antibodies Market Size by Country (2018-2023)
6.4 North America HER2 Antibodies Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HER2 Antibodies Market Size (2018-2033)
7.2 Europe HER2 Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe HER2 Antibodies Market Size by Country (2018-2023)
7.4 Europe HER2 Antibodies Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibodies Market Size (2018-2033)
8.2 Asia-Pacific HER2 Antibodies Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific HER2 Antibodies Market Size by Region (2018-2023)
8.4 Asia-Pacific HER2 Antibodies Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HER2 Antibodies Market Size (2018-2033)
9.2 Latin America HER2 Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America HER2 Antibodies Market Size by Country (2018-2023)
9.4 Latin America HER2 Antibodies Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibodies Market Size (2018-2033)
10.2 Middle East & Africa HER2 Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa HER2 Antibodies Market Size by Country (2018-2023)
10.4 Middle East & Africa HER2 Antibodies Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis HER2 Antibodies Introduction
11.1.4 Novartis Revenue in HER2 Antibodies Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer HER2 Antibodies Introduction
11.2.4 Pfizer Revenue in HER2 Antibodies Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche HER2 Antibodies Introduction
11.3.4 Roche Revenue in HER2 Antibodies Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Abnova
11.4.1 Abnova Company Detail
11.4.2 Abnova Business Overview
11.4.3 Abnova HER2 Antibodies Introduction
11.4.4 Abnova Revenue in HER2 Antibodies Business (2018-2023)
11.4.5 Abnova Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Detail
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibodies Introduction
11.5.4 InvivoGen Revenue in HER2 Antibodies Business (2018-2023)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Detail
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibodies Introduction
11.6.4 Celltrion Revenue in HER2 Antibodies Business (2018-2023)
11.6.5 Celltrion Recent Development
11.7 Biocon
11.7.1 Biocon Company Detail
11.7.2 Biocon Business Overview
11.7.3 Biocon HER2 Antibodies Introduction
11.7.4 Biocon Revenue in HER2 Antibodies Business (2018-2023)
11.7.5 Biocon Recent Development
11.8 Novus Biologicals
11.8.1 Novus Biologicals Company Detail
11.8.2 Novus Biologicals Business Overview
11.8.3 Novus Biologicals HER2 Antibodies Introduction
11.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2018-2023)
11.8.5 Novus Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HER2 Antibodies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibodies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global HER2 Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global HER2 Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global HER2 Antibodies Market Share by Region (2018-2023)
Table 11. Global HER2 Antibodies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global HER2 Antibodies Market Share by Region (2024-2033)
Table 13. HER2 Antibodies Market Trends
Table 14. HER2 Antibodies Market Drivers
Table 15. HER2 Antibodies Market Challenges
Table 16. HER2 Antibodies Market Restraints
Table 17. Global HER2 Antibodies Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global HER2 Antibodies Market Share by Players (2018-2023)
Table 19. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibodies as of 2022)
Table 20. Ranking of Global Top HER2 Antibodies Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by HER2 Antibodies Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HER2 Antibodies Product Solution and Service
Table 24. Date of Enter into HER2 Antibodies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HER2 Antibodies Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global HER2 Antibodies Revenue Market Share by Type (2018-2023)
Table 28. Global HER2 Antibodies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global HER2 Antibodies Revenue Market Share by Type (2024-2033)
Table 30. Global HER2 Antibodies Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global HER2 Antibodies Revenue Market Share by Application (2018-2023)
Table 32. Global HER2 Antibodies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global HER2 Antibodies Revenue Market Share by Application (2024-2033)
Table 34. North America HER2 Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America HER2 Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America HER2 Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe HER2 Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe HER2 Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe HER2 Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific HER2 Antibodies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific HER2 Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific HER2 Antibodies Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America HER2 Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America HER2 Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America HER2 Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa HER2 Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa HER2 Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa HER2 Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis HER2 Antibodies Product
Table 52. Novartis Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer HER2 Antibodies Product
Table 57. Pfizer Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Roche Company Detail
Table 60. Roche Business Overview
Table 61. Roche HER2 Antibodies Product
Table 62. Roche Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 63. Roche Recent Development
Table 64. Abnova Company Detail
Table 65. Abnova Business Overview
Table 66. Abnova HER2 Antibodies Product
Table 67. Abnova Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 68. Abnova Recent Development
Table 69. InvivoGen Company Detail
Table 70. InvivoGen Business Overview
Table 71. InvivoGen HER2 Antibodies Product
Table 72. InvivoGen Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 73. InvivoGen Recent Development
Table 74. Celltrion Company Detail
Table 75. Celltrion Business Overview
Table 76. Celltrion HER2 Antibodies Product
Table 77. Celltrion Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 78. Celltrion Recent Development
Table 79. Biocon Company Detail
Table 80. Biocon Business Overview
Table 81. Biocon HER2 Antibodies Product
Table 82. Biocon Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 83. Biocon Recent Development
Table 84. Novus Biologicals Company Detail
Table 85. Novus Biologicals Business Overview
Table 86. Novus Biologicals HER2 Antibodies Product
Table 87. Novus Biologicals Revenue in HER2 Antibodies Business (2018-2023) & (US$ Million)
Table 88. Novus Biologicals Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibodies Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global HER2 Antibodies Market Share by Type: 2022 VS 2033
Figure 3. Trastuzumab Features
Figure 4. Lapatinib Features
Figure 5. Ado-trastuzumab emtansine Features
Figure 6. Pertuzumab Features
Figure 7. Everolimus Features
Figure 8. Global HER2 Antibodies Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global HER2 Antibodies Market Share by Application: 2022 VS 2033
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. E-commerce Case Studies
Figure 13. HER2 Antibodies Report Years Considered
Figure 14. Global HER2 Antibodies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global HER2 Antibodies Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global HER2 Antibodies Market Share by Region: 2022 VS 2033
Figure 17. Global HER2 Antibodies Market Share by Players in 2022
Figure 18. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 Antibodies as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by HER2 Antibodies Revenue in 2022
Figure 20. North America HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America HER2 Antibodies Market Share by Country (2018-2033)
Figure 22. United States HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe HER2 Antibodies Market Share by Country (2018-2033)
Figure 26. Germany HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific HER2 Antibodies Market Share by Region (2018-2033)
Figure 34. China HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America HER2 Antibodies Market Share by Country (2018-2033)
Figure 42. Mexico HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa HER2 Antibodies Market Share by Country (2018-2033)
Figure 46. Turkey HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia HER2 Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 51. Abnova Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 52. InvivoGen Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 53. Celltrion Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 54. Biocon Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 55. Novus Biologicals Revenue Growth Rate in HER2 Antibodies Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed